Oxidative Stress and Vascular Disease: Insights from Isoprostane Measurement
Author:
- 1 January 2005
- journal article
- Published by Oxford University Press (OUP) in Clinical Chemistry
- Vol. 51 (1) , 14-15
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Plasma F2-Isoprostanes and Coronary Artery Calcification: The CARDIA StudyClinical Chemistry, 2005
- Measuring reactive species and oxidative damagein vivoand in cell culture: how should you do it and what do the results mean?British Journal of Pharmacology, 2004
- Inflammation meets oxidation: NF-κB as a mediator of initial lesion development in atherosclerosisTrends in Molecular Medicine, 2003
- The Isoprostanes: Unique Products of Arachidonic Acid Oxidation-A ReviewCurrent Medicinal Chemistry, 2003
- Application of Gas Chromatography-Mass Spectrometry for Analysis of Isoprostanes: Their Role in Cardiovascular DiseaseClinical Chemistry and Laboratory Medicine (CCLM), 2003
- MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20 536 high-risk individuals: a randomised placebo-controlled trialThe Lancet, 2002
- 2,3-Dinor-5,6-dihydro-15-F2t-isoprostane: a bioactive prostanoid metaboliteAmerican Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 2001
- The Oxidative Modification Hypothesis of Atherosclerosis Does It Hold for Humans?Trends in Cardiovascular Medicine, 2001
- Effect of the isoprostanes, 8-iso prostaglandin E2 and 8-iso prostaglandin F2α on the rabbit lung in vivoProstaglandins, 1997
- Lack of Effect of Long-Term Supplementation with Beta Carotene on the Incidence of Malignant Neoplasms and Cardiovascular DiseaseNew England Journal of Medicine, 1996